Mesenteric venous thrombosis

Abstract

Mesenteric venous thrombosis has an obscure etiology, a prolonged onset of symptoms, and controversial methods of diagnosis and treatment. Eleven collected patients with pathologic confirmation of this diagnosis are presented, with one patient demonstrating the endoscopic appearance of this disease in human small bowel. Other methods of diagnosis are also reviewed. Treatment of mesenteric venous thrombosis requires resection of necrotic bowel and, we believe, anticoagulation. The role of planned "second-look" laparotomy is reviewed, but it was not necessary in those patients in whom definitive resection could be combined with intraoperative anticoagulation.

Treatment with direct thrombolytic infusion via mesenteric catheter and thrombectomy in superior mesenteric vein thrombosis due to synthetic drug use

“…It was initially reported in 1935 in a patient who underwent surgery for acute intestinal ischaemia. 2 Acute MVT, responsible for approximately 5-15% of acute mesenteric ischemia, has a better clinical course than arterial occlusions. 3 The average age of MVT patients is 45-62 years.…”

Superior Mesenteric Vein Occlusion Presenting With a Massive Vascular Malformation of the Colon

“…Warren et al 1 and Donaldson et al , 2 in 1935, were the first to recognise and report superior mesenteric vein thrombosis as a distinct clinical entity. It is a rare condition found most commonly in young adults, with a slight male preponderance, and it accounts for 0.01‐0.06% of all cases of intestinal infarction 5‐7 .…”

“…Superior mesenteric vein (SMV) thrombosis is a rare condition which may present in a variety of ways ranging from vague abdominal pain to acute intestinal infarction 1,2 . The diagnosis is rarely made preoperatively because of inconsistent presenting features and because it is frequently overlooked.…”

Hypercoagulability status, operative mortality, and long-term survival in patients operated on for mesenteric venous thrombosis

“…5 Initially, it was described in 1895 by Elliot 6 and was redefined in 1935 by Warren and Eberhardt. 7 Hypercoagulability states, intra-abdominal inflammatory processes, trauma, cancer, portal hypertension, and cirrhosis are some of the risk factors for MVT. [8][9][10][11] Early diagnosis is difficult due to nonspecific clinical features and biomarkers.…”